Drug Resistance, Microbial
Research News and Information

Sunday, November 22, 2009

Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Northeastern Ohio.

30 Oct 2009 A retrospective survey was performed on all staphylococcal infections diagnosed by the Ashtabula County Medical Center (Ashtabula, OH) during 2006 and 2007. Of the 1,612 Staphylococcus aureus isolates evaluated for their antibiotic resistances, 947 ... Read more...

Biochemical characterization of the multidrug regulator QacR distinguishes residues that are crucial to multidrug binding and induction of qacA transcription.

18 Oct 2009 Staphylococcus aureus transcription factor QacR regulates expression of the qacA multidrug efflux determinant. In response to binding cationic lipophilic compounds, including ethidium and rhodamine 6G, QacR dissociates from the qacA operator ... Read more...

Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii.

29 Sep 2009 Antimicrobial therapy is the mainstay of management for community-acquired pneumonia (CAP). Accordingly, the choices of treatment are influenced by the likely etiologies, local resistance patterns of the pathogens, as well as patient factors. As the ... Read more...

Latest indexed articles for 'Drug Resistance, Microbial'

These are the very latest articles for this heading:

• Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Northeastern Ohio. 30 Oct 2009
• Biochemical characterization of the multidrug regulator QacR distinguishes residues that are crucial to multidrug binding and induction of qacA transcription. 18 Oct 2009
• Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii. 29 Sep 2009
• Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate. 29 Sep 2009
• Artemether-lumefantrine (Coartem) for treatment of malaria. 19 Sep 2009
• Selection of peptides that target the aminoacyl-tRNA site of bacterial 16S ribosomal RNA. 6 Sep 2009
• Poultry, politics, and antibiotic resistance. 3 Sep 2009
• Recommendations for antibiotics in patients with joint prosthesis are irresponsible and indefensible. 30 Aug 2009
• Prevention of febrile neutropenia: use of prophylactic antibiotics. 30 Aug 2009
• Genetic diversity of Streptococcus suis clinical isolates from pigs and humans in Italy (2003-2007). 18 Aug 2009
• Common mechanistic features among metallo-beta-lactamases: a computational study of Aeromonas hydrophila CphA enzyme. 9 Aug 2009
• Integrating physiological, ecological and evolutionary change: a Price equation approach. 30 Jul 2009
• The effect of combined tobramycin-clarithromycin on Mycobacterium tuberculosis isolates. 30 Jul 2009
• Isoniazid preventive therapy for people living with HIV: public health challenges and implementation issues. 30 Jul 2009
• The case for pathogen-specific therapy. 30 Jul 2009
• Predictors and outcomes of antibiotic adequacy for bloodstream infections in veterans with spinal cord injury. 30 Jul 2009
• Assessing the suitability of antibiotic resistance markers and the indirect ELISA technique for studying the competitive ability of selected Cyclopia Vent. rhizobia under glasshouse and field conditions in South Africa. 18 Jul 2009
• Rapid evolution of virulence and drug resistance in the emerging zoonotic pathogen Streptococcus suis. 13 Jul 2009
• Involvement of the post-transcriptional regulator Hfq in Yersinia pestis virulence. 8 Jul 2009
• Intra-abdominal infections: etiology, epidemiology, microbiological diagnosis and antibiotic resistance. 29 Jun 2009

See a longer list of these articles.

Technical information about 'Drug Resistance, Microbial'

Definition: The ability of microorganisms, especially bacteria, to resist or to become tolerant to chemotherapeutic agents, antimicrobial agents, or antibiotics. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

Descriptor UI: D004352

Alternative terms: Drug Resistance, Microbial; Drug Resistances, Microbial; Antimicrobial Drug Resistance; Antimicrobial Drug Resistances; Antibiotic Resistance, Microbial; Antibiotic Resistance; Resistance, Antibiotic;

Related Mesh Headings: Microbial Sensitivity Tests; R Factors; Superinfection; Tuberculosis, Multidrug-Resistant;

Allowable Qualifiers: ethnology; genetics; immunology; physiology; radiation effects;

Tree Number: G06.225; G07.690.320.269;

History Note: 1963; for ANTIBIOTIC RESISTANCE use DRUG RESISTANCE 2002-2007

Technical Notes: general or unspecified; prefer specifics; not for protozoa: index DRUG RESISTANCE